Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexander Reuben Opotowsky, M.D.

Co-Author

This page shows the publications co-authored by Alexander Opotowsky and Michael Landzberg.
Connection Strength

8.417
  1. Prospective cohort study of C-reactive protein as a predictor of clinical events in adults with congenital heart disease: results of the Boston adult congenital heart disease biobank. Eur Heart J. 2018 09 07; 39(34):3253-3261.
    View in: PubMed
    Score: 0.828
  2. Design and Implementation of a Prospective Adult Congenital Heart Disease Biobank. World J Pediatr Congenit Heart Surg. 2016 11; 7(6):734-743.
    View in: PubMed
    Score: 0.728
  3. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc. 2016 Jan 11; 5(1).
    View in: PubMed
    Score: 0.688
  4. Evolving perspectives on heart failure in adults with congenital heart disease. Preface. Heart Fail Clin. 2014 Jan; 10(1):xv-xvi.
    View in: PubMed
    Score: 0.598
  5. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012 Jan; 98(2):145-51.
    View in: PubMed
    Score: 0.513
  6. Bicuspid aortic valve morphology. J Am Coll Cardiol. 2010 Nov 09; 56(20):1680; author reply 1680-1.
    View in: PubMed
    Score: 0.481
  7. Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease. Am Heart J. 2020 11; 229:92-99.
    View in: PubMed
    Score: 0.236
  8. Relationship of Red Cell Distribution Width to Adverse Outcomes in Adults With Congenital Heart Disease (from the Boston Adult Congenital Heart Biobank). Am J Cardiol. 2018 11 01; 122(9):1557-1564.
    View in: PubMed
    Score: 0.206
  9. Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank. JAMA Cardiol. 2018 04 01; 3(4):308-316.
    View in: PubMed
    Score: 0.201
  10. A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care for Adults With Congenital Heart Disease. World J Pediatr Congenit Heart Surg. 2018 03; 9(2):185-193.
    View in: PubMed
    Score: 0.200
  11. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise. PLoS One. 2017; 12(6):e0179053.
    View in: PubMed
    Score: 0.190
  12. Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation. Am Heart J. 2017 Jul; 189:184-192.
    View in: PubMed
    Score: 0.188
  13. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise: A Hemodynamic Observation. J Am Coll Cardiol. 2017 02 07; 69(5):595-597.
    View in: PubMed
    Score: 0.185
  14. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation. Heart. 2017 03; 103(6):434-442.
    View in: PubMed
    Score: 0.181
  15. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease. J Clin Endocrinol Metab. 2015 Apr; 100(4):1325-34.
    View in: PubMed
    Score: 0.161
  16. Exercise oscillatory ventilation in patients with Fontan physiology. Circ Heart Fail. 2015 Mar; 8(2):304-11.
    View in: PubMed
    Score: 0.160
  17. Impaired exercise capacity following atrial septal defect closure: an invasive study of the right heart and pulmonary circulation. Pulm Circ. 2014 Dec; 4(4):630-7.
    View in: PubMed
    Score: 0.159
  18. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses. Can J Cardiol. 2014 Oct; 30(10):1216-24.
    View in: PubMed
    Score: 0.153
  19. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. . 2014 Jul 01; 307(1):H110-7.
    View in: PubMed
    Score: 0.153
  20. The exceptional and far-flung manifestations of heart failure in Eisenmenger syndrome. Heart Fail Clin. 2014 Jan; 10(1):91-104.
    View in: PubMed
    Score: 0.150
  21. Towards widespread noninvasive assessment of pulmonary vascular resistance in clinical practice. J Am Soc Echocardiogr. 2014 Jan; 27(1):108-9.
    View in: PubMed
    Score: 0.148
  22. Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta. Congenit Heart Dis. 2014 May-Jun; 9(3):235-43.
    View in: PubMed
    Score: 0.144
  23. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013 Sep 15; 112(6):873-82.
    View in: PubMed
    Score: 0.144
  24. The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010. JAMA. 2013 Mar 13; 309(10):984-986.
    View in: PubMed
    Score: 0.141
  25. Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol. 2013 Apr 01; 111(7):1046-51.
    View in: PubMed
    Score: 0.140
  26. A shifting approach to management of the thoracic aorta in bicuspid aortic valve. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):339-46.
    View in: PubMed
    Score: 0.138
  27. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013 Sep 01; 167(5):1918-23.
    View in: PubMed
    Score: 0.135
  28. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011 May 15; 107(10):1529-34.
    View in: PubMed
    Score: 0.123
  29. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events. Am Heart J. 2009 May; 157(5):867-74.
    View in: PubMed
    Score: 0.108
  30. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA. 2008 Feb 06; 299(5):521-2.
    View in: PubMed
    Score: 0.099
  31. Tuning and External Validation of an Adult Congenital Heart Disease Risk Prediction Model. Eur Heart J Qual Care Clin Outcomes. 2020 Dec 12.
    View in: PubMed
    Score: 0.061
  32. Disparities in Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation Before and Since Revision of Status I Listing. Am J Cardiol. 2018 11 15; 122(10):1761-1764.
    View in: PubMed
    Score: 0.052
  33. A Pilot Study of Inspiratory Muscle Training to Improve Exercise Capacity in Patients with Fontan Physiology. Semin Thorac Cardiovasc Surg. 2018 Winter; 30(4):462-469.
    View in: PubMed
    Score: 0.051
  34. Accuracy of Echocardiography to Estimate Pulmonary Artery Pressures With Exercise: A Simultaneous Invasive-Noninvasive Comparison. Circ Cardiovasc Imaging. 2017 Apr; 10(4).
    View in: PubMed
    Score: 0.047
  35. Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study. Circulation. 2017 Apr 11; 135(15):1432-1440.
    View in: PubMed
    Score: 0.046
  36. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015 Jul; 34(7):883-91.
    View in: PubMed
    Score: 0.040
  37. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014 Sep-Oct; 9(5):438-47.
    View in: PubMed
    Score: 0.037
  38. Clinical research priorities in adult congenital heart disease. Int J Cardiol. 2014 Feb 15; 171(3):351-60.
    View in: PubMed
    Score: 0.037
  39. Physical activity is associated with improved aerobic exercise capacity over time in adults with congenital heart disease. Int J Cardiol. 2013 Oct 12; 168(5):4685-91.
    View in: PubMed
    Score: 0.036
  40. Improving heart disease knowledge and research participation in adults with congenital heart disease (the Health, Education and Access Research Trial: HEART-ACHD). Int J Cardiol. 2013 Oct 09; 168(4):3236-40.
    View in: PubMed
    Score: 0.036
  41. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013 May 28; 61(21):2180-4.
    View in: PubMed
    Score: 0.035
  42. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7.
    View in: PubMed
    Score: 0.035
  43. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013 Jul; 29(7):866-72.
    View in: PubMed
    Score: 0.035
  44. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013 Jan 15; 127(2):172-9.
    View in: PubMed
    Score: 0.035
  45. Correlation of exercise response in repaired coarctation of the aorta to left ventricular mass and geometry. Am J Cardiol. 2013 Feb 01; 111(3):406-11.
    View in: PubMed
    Score: 0.035
  46. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83.
    View in: PubMed
    Score: 0.034
  47. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010 Aug 31; 122(9):868-75.
    View in: PubMed
    Score: 0.030
  48. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010 Jul 06; 56(2):144-50.
    View in: PubMed
    Score: 0.029
  49. Multicenter research in adult congenital heart disease. Int J Cardiol. 2008 Sep 26; 129(2):155-9.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.